3D porous bioceramic based boron-doped hydroxyapatite/baghdadite composite scaffolds for bone tissue engineering

Current bone tissue engineering strategies rely heavily on scaffold materials that can mimic natural bone structure and function. While hydroxyapatite-based scaffolds are widely used for their biocompatibility, they often struggle with low degradation rates and insufficient mechanical strength for cancellous bone applications. Prior research has shown that incorporating secondary phases like baghdadite may improve scaffold properties. However, the specific effects of combining boron-doped hydroxyapatite with baghdadite remain underexplored. This gap motivated the synthesis of novel composite scaffolds to evaluate their physicochemical, mechanical, and biological performance. No prior work had resolved how boron-doping and baghdadite integration could synergistically enhance scaffold behavior. The need for a material that balances degradation rate, mechanical strength, and bioactivity remains unmet in current literature.

This study aimed to develop and evaluate a novel composite scaffold by combining boron-doped hydroxyapatite with baghdadite. The primary goal was to determine whether this combination could address the limitations of pure hydroxyapatite scaffolds, particularly in terms of degradation rate and mechanical performance. The specific problem addressed was the slow degradation of hydroxyapatite, which hinders its ability to transfer load to newly formed bone tissue. By introducing baghdadite, the researchers sought to enhance porosity, surface area, and biodegradation rates. The motivation stemmed from the need for a scaffold that supports osteogenic differentiation while maintaining structural integrity. The study also aimed to assess how this combination affects cell proliferation and mechanical strength. The ultimate objective was to create a scaffold that satisfies multiple tissue engineering requirements simultaneously.

The researchers fabricated 3D porous composite scaffolds using boron-doped hydroxyapatite as the primary component and varying amounts of baghdadite as the secondary component. The scaffolds were produced using a ceramic-based fabrication method that allowed control over porosity and surface area. Physicochemical properties were analyzed using standard characterization techniques to assess porosity, surface area, and micropore volume. Mechanical strength was evaluated through compressive strength testing. Biodegradation rates were measured under simulated physiological conditions. Biological performance was assessed using cell proliferation and osteogenic differentiation assays. The effects of baghdadite content on scaffold properties were systematically investigated. The study compared the composite scaffolds with pure boron-doped hydroxyapatite scaffolds and existing literature data.

The addition of baghdadite increased scaffold porosity to over 40%, with larger surface area and micropore volumes compared to pure hydroxyapatite scaffolds. The composite scaffolds exhibited higher biodegradation rates, aligning with the required degradation for gradual load transfer to new bone tissue. Osteogenic differentiation was significantly enhanced in scaffolds containing more than 10% baghdadite. Cell proliferation was also improved due to both physical and chemical modifications in the composite structure. Compressive strength remained slightly lower than pure hydroxyapatite scaffolds but exceeded most previously reported composite scaffolds with baghdadite. The mechanical performance was sufficient for cancellous bone defect applications. The combined advantages of both materials in the composite scaffolds were clearly demonstrated. These results suggest that the composite design effectively addresses multiple tissue engineering requirements.

The study demonstrated that incorporating baghdadite into boron-doped hydroxyapatite scaffolds significantly improved porosity, surface area, and biodegradation rates. The composite scaffolds achieved a degradation rate suitable for bone tissue regeneration. Enhanced osteogenic differentiation was observed in scaffolds with higher baghdadite content. Mechanical strength remained adequate for cancellous bone applications despite being slightly lower than pure hydroxyapatite scaffolds. The composite design successfully combined the benefits of both materials. The results suggest that these scaffolds could meet the diverse requirements of bone tissue engineering. The findings align with the authors' claim that the composite scaffolds represent a step toward ideal scaffold fabrication. The study supports the potential of this composite material for future clinical applications.